Opinion|Videos|November 30, 2023
Collaborating With Your Oncology Care Team to Manage Side Effects of HER2-Positive Metastatic Breast Cancer Treatment
Author(s)Sara M. Tolaney, MD, MPH
Patients with metastatic breast cancer receiving HER2-targeted therapies should promptly report any respiratory symptoms or signs of lung and heart disease to their oncology care team to facilitate early intervention and management of side effects.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
From Stage 4 to Survivor: Dan’s Pancreatic Cancer Journey
2
Giredestrant Improves Outcomes in ER+/HER2– Breast Cancer
3
Tukysa Combo Boosts Frontline Maintenance in Advanced HER2+ Breast Cancer
4
Suleika Jaouad Celebrates Blood Cancer Heroes With CURE and Blood Cancer United
5
